Hannah Valantine, Director: BridgeBio Pharma BBIO Sell · Filed 24/02/20

Trade details

Type: Insider sale
Amount: $110,041.25
Shares · price: 2,915 sh · $37.75 a share
Held after: 1,764 sh
Stock: BridgeBio Pharma BBIO
Person: Hannah ValantineDirector
Trade date: 24/02/15
Filed: 24/02/20
Days to filing: 5 days

Sold 62.3% of holdings

Share of holding sold: 62.3%

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 24/01/16~24/03/16

Hannah Valantine's recent trades

Hannah ValantineDirector
Planned sale10b5-1 planCareDx
Planned sale10b5-1 plan
CareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/22
Traded 06/22